Polarean Imaging PLC Ordinary Shares (POLX)

Industry Medical Devices


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.15p

Buy

0.16p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 14:49 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Polarean Imaging PLC and its subsidiary are engaged in developing next generation medical imaging technology. It develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Kenneth West
CEO
Dr. Christopher Richard von Jako
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
16
Head office
27-28 Eastcastle Street
London
United Kingdom
W1W 8DH
mobile
-
letter
info@polarean.com

Key personnel

Salary
Mr. Kenneth West
Non-Executive Director, Chairman
-
Mr. Cyrille Yann Nicolas Petit
Non-Executive Director
-
Mr. Frank Maria Schulkes
Non-Executive Director
-
Mr. Juergen Laucht
Non-Executive Director
-
Mr. Daniel Myron Brague
Non-Executive Director
-
Mr. Charles Fremont Osborne Jr
Executive Director, Chief Financial Officer
-
Dr. Christopher Richard von Jako
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
Unicorn Asset Management Ltd38,178,800
Unicorn AIM VCT Series 3 ORD38,178,800
Hargreave Hale Limited5,802,356
Hargreave Hale AIM VCT5,802,356
Pinnacle Associates Inc600,000

Director dealings

Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.